快速双参数与多参数磁共振在前列腺特异性抗原升高男性分诊中的前瞻性对照试验
PRO-TRIAGE前瞻性随机对照试验纳入364名PSA升高男性,1:1随机分配至快速双参数MRI(fast-bpMRI)或多参数MRI(mpMRI)组,由两名不同阅片者按PI-RADS v2.1评估。结果显示fast-bpMRI组需活检比例53.6%略高于mpMRI组50.8%(p=0.28),临床显著前列腺癌检出率均为26.4%,诊断性能无显著差异。
要点
- fast-bpMRI与mpMRI需活检比例无统计学差异(53.6% vs 50.8%,p=0.28)
- 两种方案临床显著前列腺癌检出率均为26.4%
- 以PI-RADS≥3为阈值,fast-bpMRI灵敏度92.8%、mpMRI 90.7%(p=0.41)
核心结论
- fast-bpMRI较mpMRI略微增加需活检男性比例,但临床显著前列腺癌检出率相当。
研究设计与样本
- fast-bpMRI与mpMRI扫描按1:1随机分配至两名不同阅片者,采用PI-RADS v2.1评估。
- 第三名不知晓MRI方案的研究者审核报告并识别PI-RADS≥3可疑病灶后执行活检。
主要发现
- fast-bpMRI组需活检人数195例(53.6%),mpMRI组185例(50.8%),p=0.28。
- PI-RADS 3 equivocal病例fast-bpMRI组65例(17.9%),mpMRI组58例(15.9%),p=0.46。
- 临床显著前列腺癌(Gleason评分≥3+4)检出率两种方案均为26.4%。
- 以PI-RADS≥3为阈值,fast-bpMRI检测csPC灵敏度92.8%、mpMRI 90.7%(p=0.41)。
- 特异度fast-bpMRI为53.8%、mpMRI为56.7%(p=0.52)。
临床怎么用
- 在PSA升高男性分诊中,fast-bpMRI可作为mpMRI的替代方案,临床显著前列腺癌检出率相当。
- 采用fast-bpMRI需预期活检比例可能略高,应结合临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The increasing demand for prostate magnetic resonance imaging (MRI) underscores the need for better accessibility. We conducted a prospective study to compare fast biparametric MRI (fast-bpMRI) with multiparametric MRI (mpMRI) in terms of the number of men requiring biopsy and the detection rate for clinically significant prostate cancer (csPC). METHODS: From May 2021 to December 2023, fast-bpMRI and mpMRI scans for 364 men were randomly assigned at a 1:1 ratio to two different readers for evaluation using Prostate Imaging-Reporting and Data System (PI-RADS) version 2.1. A third researcher who was unaware of the MRI protocol used reviewed the readers' report to identify MRI-suspicious lesions (PI-RADS ≥3) and performed biopsy. The primary outcome was the proportion of men requiring biopsy. Secondary outcomes were the proportion of equivocal cases (PI-RADS 3), csPC detection rates (Gleason score ≥ 3 + 4), and diagnostic performance for csPC detection. The PRO-TRIAGE study was registered on cris.nih.go.kr as KCT0006181. KEY FINDINGS AND LIMITATIONS: The number of men requiring biopsy for MRI-suspicious lesions (PI-RADS ≥3) was 195 (53.6%) according to fast-bpMRI and 185 (50.8%) according to mpMRI (p = 0.28). Equivocal cases (PI-RADS 3) were observed in 65 men (17.9%) according to fast-bpMRI and 58 (15.9%) according to mpMRI (p = 0.46). The csPC detection rate was 26.4% for both protocols. Using PI-RADS ≥3 as a cutoff, the sensitivity for csPC detection was 92.8% with fast-bpMRI and 90.7% with mpMRI (p = 0.41), while the specificity was 53.8% with fast-bpMRI and 56.7% with mpMRI (p = 0.52). CONCLUSIONS AND CLINICAL IMPLICATIONS: Fast-bpMRI resulted in a slightly higher proportion of men requiring biopsy in comparison to mpMRI, with a comparable csPC detection rate.
引用
- Ahn H, Park MY, Shin JI, et al. Fast Biparametric Versus Multiparametric Magnetic Resonance Imaging for Triage of Men with Elevated Prostate-specific Antigen: The PRO-TRIAGE Prospective Comparative Trial. Eur Urol Oncol. 2025. PMID: 40713295. doi:10.1016/j.euo.2025.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。